Hemoglobin A1c (HbA1c) Testing Market 2024: Advances in Diabetes Monitoring and Diagnostic Technologies

"The Business Research Company recently released a comprehensive report on the Global Hemoglobin A1c (HbA1c) Testing Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.

According to The Business Research Company's, The hemoglobin A1c (HbA1c) testing market size has grown rapidly in recent years. It will grow from $1.66 billion in 2023 to $1.83 billion in 2024 at a compound annual growth rate (CAGR) of 10.4%. The growth in the historic period can be attributed to the increasing prevalence of diabetes, growing awareness and screening programs, growing government initiatives and healthcare policies, increasing healthcare infrastructure development, a growing aging population, improved diagnostic accuracy, and increased adoption of point-of-care testing.

The hemoglobin A1c (HbA1c) testing market size is expected to see rapid growth in the next few years. It will grow to $2.74 billion in 2028 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to rising prevalence of lifestyle diseases, increased focus on preventive healthcare, expansion in emerging markets, increasing personalized medicine and patient-centric care, regulatory support and reimbursement policies, growing telemedicine, and remote monitoring. Major trends in the forecast period include technological advancements, integration with digital health platforms, advancements in non-invasive testing technologies, expansion in telehealth, and remote patient monitoring.

Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/hemoglobin-a1c-hba1c-testing-global-market-report

Market Drivers and Trends:

The increasing prevalence of diabetes is expected to propel the growth of the hemoglobin A1c (HbA1c) testing market going forward. Diabetes is a chronic medical condition where the body cannot properly regulate blood glucose levels due to insufficient insulin production or insulin resistance. The diabetes case are rising due to poor diet, especially high consumption of processed foods and sugary drinks, and sedentary lifestyles characterized by minimal physical activity. Moreover, the aging population and family history of diabetes increase the probability of diabetes. HbA1c testing is used to monitor long-term blood glucose control in individuals with diabetes by measuring the average level of blood sugar over the past 2-3 months. For instance, in June 2023, according to the data published by The Lancet, a UK-based book and periodic data publishing organization, global diabetes cases are projected to increase from 529 million in 2021 to 1.3 billion by 2050. Therefore, the increasing prevalence of diabetes will drive the growth of the hemoglobin A1c (HbA1c) testing market.

Major companies operating in the hemoglobin A1c (HbA1c) testing market are focusing on the development of automated HbA1c analyzers, such as high-performance liquid chromatography (HPLC) technology-based solutions, to enhance accuracy and efficiency in diabetes diagnosis and monitoring. High-performance liquid chromatography (HPLC) technology-based solutions in HbA1c testing refers to advanced methods for accurately measuring hemoglobin variants in blood to monitor long-term glucose control in diabetic patients. For instance, in June 2021, Trivitron Healthcare Private Limited, an India-based healthcare and medical technology company, launched the NANO H5 and NANO H110. The NANO H5 is a compact, automated HPLC analyzer that provides quantitative determination of glycated hemoglobin (HbA1c) in human whole blood with a processing time of 130 seconds, allowing for rapid laboratory turnaround. It can process up to five samples simultaneously. The NANO H110 is another compact, automated HPLC analyzer that features dual test modes for both HbA1c and Hb Variant detection. It includes advanced features such as a barcode scanner and cap piercing, with a high sample loading capacity of 110 samples, making it ideal for medium- to large-sized laboratories.

Key Benefits for Stakeholders:

• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.

Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=18632&type=smp

Major Key Players of the Market:

Roche Holding AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers, Tosoh Corporation, Hitachi High-Technologies Corporation, Beckman Coulter Inc, Sysmex Corporation, Bio Rad Laboratories Inc, ARKRAY Inc, Randox Laboratories Ltd, Ortho Clinical Diagnostics, Agappe Diagnostics Ltd, SEKISUI Diagnostics LLC, Helena Laboratories, Transasia Bio Medicals Ltd, EKF Diagnostics, Trinity Biotech plc, HemoCue AB, CPC Diagnostics Pvt Ltd, PTS Diagnostics, Menarini Diagnostics srl, Diazyme Laboratories Inc, Osang HealthCare Co Ltd, Eurolyser Diagnostica GmbH, DiaSys Diagnostic Systems GmbH

Hemoglobin A1c (HbA1c) Testing Market 2024 Key Insights:

• The hemoglobin a1c (hba1c) testing market is expected to grow to $2.74 billion in 2028 at a compound annual growth rate (CAGR) of 10.6%.
• Increasing Diabetes Prevalence To Boost HbA1c Testing Demand
• New Rapid And Precise HPLC Analyzers Advances HbA1c Testing Market
• North America was the largest region in the hemoglobin A1c (HbA1c) testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hemoglobin A1c (HbA1c) testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/customise?id=18632&type=smp

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.